Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Menezes

Showing results (51-60 of 301) with videos related to

Pageof 31
Sort By:
International Journal of Immunopharmacology|January 1, 1985
Isoprinosine enhances the activation of sensitized lymphocytes by Epstein-Barr virus antigensS K Sundar, G Barile, J Menezes
IARC Scientific Publications|January 1, 1975
Specific IgM response and characteristics of the lymphoblastoid cell lines obtained from an infant with probable mixed cytomegalovirus and Epstein-Barr virus infectionJ H Joncas, J Menezes, G Lussier
Clinical and Experimental Immunology|September 1, 1979
Comparative studies on the expression of Fc-receptors, Ia antigens, and beta 2-microglobulin following in vitro herpes simplex virus infection of human lymphoid cellsG Dorval, A E Bourkas, J Menezes
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1997
Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 inductionB N Atedzoe, A Ahmad, J Menezes
Infection and Immunity|October 1, 1982
Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell linesP C Patel, G Dorval, J Menezes
International Journal of Cancer|October 2, 2003
Physical activity and risk of renal cell carcinomaRavi J Menezes, George Tomlinson, Nancy Kreiger
Experimental Biology|January 1, 1985
Synthesis and release of plasminogen activator by lymphoid cell lines of malignant origin and its effect on lymphocyte cytotoxicityS K Sundar, J Bergeron, J Menezes
International Journal of Cancer|June 19, 1991
Establishment and characterization of Epstein-Barr virus gp350-expressing transfected human lymphoid (Raji) cell clonesM Khyatti, P C Patel, J Menezes
Clinical and Experimental Immunology|June 1, 1984
Purified plasminogen activating factor produced by malignant lymphoid cells abrogates lymphocyte cytotoxicityS K Sundar, J Bergeron, J Menezes
Journal of Molecular Biology|May 10, 2000
Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-alpha gene expression in monocytic cells via NF-kappaB involving PKC, PI3-K and tyrosine kinasesM D'Addario, A Ahmad, A Morgan, et al.
Pageof 31

Showing results (51-60 of 301) with videos related to

Sort By:
Pageof 31
International Journal of Immunopharmacology|January 1, 1985
Isoprinosine enhances the activation of sensitized lymphocytes by Epstein-Barr virus antigensS K Sundar, G Barile, J Menezes
IARC Scientific Publications|January 1, 1975
Specific IgM response and characteristics of the lymphoblastoid cell lines obtained from an infant with probable mixed cytomegalovirus and Epstein-Barr virus infectionJ H Joncas, J Menezes, G Lussier
Clinical and Experimental Immunology|September 1, 1979
Comparative studies on the expression of Fc-receptors, Ia antigens, and beta 2-microglobulin following in vitro herpes simplex virus infection of human lymphoid cellsG Dorval, A E Bourkas, J Menezes
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1997
Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 inductionB N Atedzoe, A Ahmad, J Menezes
Infection and Immunity|October 1, 1982
Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell linesP C Patel, G Dorval, J Menezes
International Journal of Cancer|October 2, 2003
Physical activity and risk of renal cell carcinomaRavi J Menezes, George Tomlinson, Nancy Kreiger
Experimental Biology|January 1, 1985
Synthesis and release of plasminogen activator by lymphoid cell lines of malignant origin and its effect on lymphocyte cytotoxicityS K Sundar, J Bergeron, J Menezes
International Journal of Cancer|June 19, 1991
Establishment and characterization of Epstein-Barr virus gp350-expressing transfected human lymphoid (Raji) cell clonesM Khyatti, P C Patel, J Menezes
Clinical and Experimental Immunology|June 1, 1984
Purified plasminogen activating factor produced by malignant lymphoid cells abrogates lymphocyte cytotoxicityS K Sundar, J Bergeron, J Menezes
Journal of Molecular Biology|May 10, 2000
Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-alpha gene expression in monocytic cells via NF-kappaB involving PKC, PI3-K and tyrosine kinasesM D'Addario, A Ahmad, A Morgan, et al.
Pageof 31